Vaccination of Patients With Breast Cancer With Dendritic Cell/Tumor Fusions and IL-12
Clinical trial NCT00622401 · TERMINATED
Trial details
- NCT number
- NCT00622401
- Sponsor
- Beth Israel Deaconess Medical Center
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2014-10-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.